Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
Journal of Pediatric Hematology/Oncology
|
August 1, 1995
Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II study
F H Kung, S J Desai, J D Dickerman, et al.
Haematology and Blood Transfusion
|
January 1, 1989
Use of investigational drugs as initial therapy for childhood solid tumors
W H Meyer, P J Houghton, M E Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1986
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution
M E Horowitz, C B Pratt, B L Webber, et al.
The New England Journal of Medicine
|
June 19, 1986
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
M P Link, A M Goorin, A W Miser, et al.
Medical and Pediatric Oncology
|
February 25, 1998
A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas
A W Walter, P D Shearer, A S Pappo, et al.
Seminars in Oncology
|
February 1, 1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988
C B Pratt, E C Douglass, E Etcubanas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy
W L Furman, D L Fairclough, R D Huhn, et al.
Journal of Pediatric Hematology/Oncology
|
November 1, 1996
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study
D G Tubergen, C F Stewart, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital
S L Spunt, C A Poquette, Y S Hurt, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Ifosfamide in pediatric malignant solid tumors
C B Pratt, E C Douglass, E L Etcubanas, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
Journal of Pediatric Hematology/Oncology
|
August 1, 1995
Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II study
F H Kung, S J Desai, J D Dickerman, et al.
Haematology and Blood Transfusion
|
January 1, 1989
Use of investigational drugs as initial therapy for childhood solid tumors
W H Meyer, P J Houghton, M E Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1986
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution
M E Horowitz, C B Pratt, B L Webber, et al.
The New England Journal of Medicine
|
June 19, 1986
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
M P Link, A M Goorin, A W Miser, et al.
Medical and Pediatric Oncology
|
February 25, 1998
A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas
A W Walter, P D Shearer, A S Pappo, et al.
Seminars in Oncology
|
February 1, 1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988
C B Pratt, E C Douglass, E Etcubanas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy
W L Furman, D L Fairclough, R D Huhn, et al.
Journal of Pediatric Hematology/Oncology
|
November 1, 1996
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study
D G Tubergen, C F Stewart, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital
S L Spunt, C A Poquette, Y S Hurt, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Ifosfamide in pediatric malignant solid tumors
C B Pratt, E C Douglass, E L Etcubanas, et al.
Page
of 26